Literature DB >> 19728977

Repetitive noninvasive monitoring of HSV1-tk-expressing T cells intravenously infused into nonhuman primates using positron emission tomography and computed tomography with 18F-FEAU.

Gianpietro Dotti1, Mei Tian, Barbara Savoldo, Amer Najjar, Laurence J N Cooper, James Jackson, Amanda Smith, Osama Mawlawi, Rajesh Uthamanthil, Agatha Borne, David Brammer, Vincenzo Paolillo, Mian Alauddin, Carlos Gonzalez, David Steiner, William K Decker, Frank Marini, Steven Kornblau, Catherine M Bollard, Elizabeth J Shpall, Juri G Gelovani.   

Abstract

Adoptive transfer of antigen-specific cytotoxic T lymphocytes (CTLs) has been successfully used to treat patients with different types of cancer. However, the long-term spatial-temporal dynamics of the distribution of systemically infused CTLs remains largely unknown. Noninvasive imaging of adoptively transferred CTLs using molecular-genetic reporter imaging with positron emission tomography and computed tomography (PET-CT) represents an innovative approach to understanding the long-term migratory patterns and therapeutic potential of adoptively transferred T cells. Here we report the application of repetitive PET-CT imaging with [18F]fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil (18F-FEAU) in two nonhuman primates demonstrating that autologous polyclonal macaque T lymphocytes activated and transduced with a retroviral vector encoding for the sr39 mutant herpes simplex virus 1 thymidine kinase (sr39HSV1-tk) reporter gene can be detected after intravenous infusion in discrete lymphoid organs and in sites of inflammation. This study represents a proof of principle and supports the application of 18F-FEAU PET-CT imaging for monitoring the distribution of intravenously administered sr39HSV1-tk gene-transduced CTLs in humans.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19728977      PMCID: PMC3178066     

Source DB:  PubMed          Journal:  Mol Imaging        ISSN: 1535-3508            Impact factor:   4.488


  21 in total

1.  Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells.

Authors:  C Yee; J A Thompson; D Byrd; S R Riddell; P Roche; E Celis; P D Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-11       Impact factor: 11.205

2.  Cancer regression in patients after transfer of genetically engineered lymphocytes.

Authors:  Richard A Morgan; Mark E Dudley; John R Wunderlich; Marybeth S Hughes; James C Yang; Richard M Sherry; Richard E Royal; Suzanne L Topalian; Udai S Kammula; Nicholas P Restifo; Zhili Zheng; Azam Nahvi; Christiaan R de Vries; Linda J Rogers-Freezer; Sharon A Mavroukakis; Steven A Rosenberg
Journal:  Science       Date:  2006-08-31       Impact factor: 47.728

3.  Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.

Authors:  Patrizia Comoli; Paolo Pedrazzoli; Rita Maccario; Sabrina Basso; Ornella Carminati; Massimo Labirio; Roberta Schiavo; Simona Secondino; Chiara Frasson; Cesare Perotti; Mauro Moroni; Franco Locatelli; Salvatore Siena
Journal:  J Clin Oncol       Date:  2005-10-03       Impact factor: 44.544

4.  Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).

Authors:  Barbara Savoldo; John A Goss; Markus M Hammer; Lan Zhang; Teresita Lopez; Adrian P Gee; Yu-Feng Lin; Ruben E Quiros-Tejeira; Petra Reinke; Stephan Schubert; Stephen Gottschalk; Milton J Finegold; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop
Journal:  Blood       Date:  2006-07-11       Impact factor: 22.113

5.  Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction.

Authors:  S A Rosenberg; P Aebersold; K Cornetta; A Kasid; R A Morgan; R Moen; E M Karson; M T Lotze; J C Yang; S L Topalian
Journal:  N Engl J Med       Date:  1990-08-30       Impact factor: 91.245

6.  Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs.

Authors:  Amer M Najjar; Ryuichi Nishii; David S Maxwell; Andrei Volgin; Uday Mukhopadhyay; William G Bornmann; William Tong; Mian Alauddin; Juri G Gelovani
Journal:  J Nucl Med       Date:  2009-02-17       Impact factor: 10.057

7.  Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes.

Authors:  H E Heslop; C Y Ng; C Li; C A Smith; S K Loftin; R A Krance; M K Brenner; C M Rooney
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

8.  Treatment of nasopharyngeal carcinoma with Epstein-Barr virus--specific T lymphocytes.

Authors:  Karin C M Straathof; Catherine M Bollard; Uday Popat; M Helen Huls; Teresita Lopez; M Craig Morriss; Mary V Gresik; Adrian P Gee; Heidi V Russell; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop
Journal:  Blood       Date:  2004-11-12       Impact factor: 22.113

9.  Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease.

Authors:  Catherine M Bollard; Laura Aguilar; Karin C Straathof; Benedikt Gahn; M Helen Huls; Alexandra Rousseau; John Sixbey; M Victoria Gresik; George Carrum; Melissa Hudson; Dagmar Dilloo; Adrian Gee; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop
Journal:  J Exp Med       Date:  2004-12-20       Impact factor: 14.307

10.  Safety of retroviral gene marking with a truncated NGF receptor.

Authors:  C Bonini; M Grez; C Traversari; F Ciceri; S Marktel; G Ferrari; M Dinauer; M Sadat; A Aiuti; S Deola; M Radrizzani; A Hagenbeek; J Apperley; S Ebeling; A Martens; H J Kolb; M Weber; F Lotti; A Grande; E Weissinger; J A Bueren; M Lamana; J H F Falkenburg; M H M Heemskerk; T Austin; S Kornblau; F Marini; C Benati; Z Magnani; S Cazzaniga; S Toma; C Gallo-Stampino; M Introna; S Slavin; P D Greenberg; M Bregni; F Mavilio; C Bordignon
Journal:  Nat Med       Date:  2003-04       Impact factor: 53.440

View more
  16 in total

1.  Structure-guided engineering of human thymidine kinase 2 as a positron emission tomography reporter gene for enhanced phosphorylation of non-natural thymidine analog reporter probe.

Authors:  Dean O Campbell; Shahriar S Yaghoubi; Ying Su; Jason T Lee; Martin S Auerbach; Harvey Herschman; Nagichettiar Satyamurthy; Johannes Czernin; Arnon Lavie; Caius G Radu
Journal:  J Biol Chem       Date:  2011-11-09       Impact factor: 5.157

Review 2.  The Immunoimaging Toolbox.

Authors:  Aaron T Mayer; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2018-05-24       Impact factor: 10.057

3.  Imaging of Sleeping Beauty-Modified CD19-Specific T Cells Expressing HSV1-Thymidine Kinase by Positron Emission Tomography.

Authors:  Amer M Najjar; Pallavi R Manuri; Simon Olivares; Leo Flores; Tiejuan Mi; Helen Huls; Elizabeth J Shpall; Richard E Champlin; Nashaat Turkman; Vincenzo Paolillo; Jason Roszik; Brian Rabinovich; Dean A Lee; Mian Alauddin; Juri Gelovani; Laurence J N Cooper
Journal:  Mol Imaging Biol       Date:  2016-12       Impact factor: 3.488

Review 4.  Non-invasive cell tracking in cancer and cancer therapy.

Authors:  Hao Hong; Yunan Yang; Yin Zhang; Weibo Cai
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

5.  Imaging of genetically engineered T cells by PET using gold nanoparticles complexed to Copper-64.

Authors:  Parijat Bhatnagar; Zheng Li; Yoonsu Choi; Jianfeng Guo; Feng Li; Daniel Y Lee; Matthew Figliola; Helen Huls; Dean A Lee; Tomasz Zal; King C Li; Laurence J N Cooper
Journal:  Integr Biol (Camb)       Date:  2013-01       Impact factor: 2.192

6.  Thymidine kinase suicide gene-mediated ganciclovir ablation of autologous gene-modified rhesus hematopoiesis.

Authors:  Cecilia N Barese; Allen E Krouse; Mark E Metzger; Connor A King; Catia Traversari; Frank C Marini; Robert E Donahue; Cynthia E Dunbar
Journal:  Mol Ther       Date:  2012-08-21       Impact factor: 11.454

Review 7.  Immunotherapy of human cancers using gene modified T lymphocytes.

Authors:  Juan F Vera; Malcolm K Brenner; Gianpietro Dotti
Journal:  Curr Gene Ther       Date:  2009-10       Impact factor: 4.391

8.  Imaging long-term fate of intramyocardially implanted mesenchymal stem cells in a porcine myocardial infarction model.

Authors:  Emerson C Perin; Mei Tian; Frank C Marini; Guilherme V Silva; Yi Zheng; Fred Baimbridge; Xin Quan; Marlos R Fernandes; Amir Gahremanpour; Daniel Young; Vincenzo Paolillo; Uday Mukhopadhyay; Agatha T Borne; Rajesh Uthamanthil; David Brammer; James Jackson; William K Decker; Amer M Najjar; Michael W Thomas; Andrei Volgin; Brian Rabinovich; Suren Soghomonyan; Hwan-Jeong Jeong; Jesse M Rios; David Steiner; Simon Robinson; Osama Mawlawi; Tinsu Pan; Jason Stafford; Vikas Kundra; Chun Li; Mian M Alauddin; James T Willerson; Elizabeth Shpall; Juri G Gelovani
Journal:  PLoS One       Date:  2011-09-01       Impact factor: 3.240

9.  Positron emission tomography reporter genes and reporter probes: gene and cell therapy applications.

Authors:  Shahriar S Yaghoubi; Dean O Campbell; Caius G Radu; Johannes Czernin
Journal:  Theranostics       Date:  2012-04-10       Impact factor: 11.556

10.  Radionuclide-based molecular imaging allows CAR-T cellular visualization and therapeutic monitoring.

Authors:  Fuqiang Shao; Yu Long; Hao Ji; Dawei Jiang; Ping Lei; Xiaoli Lan
Journal:  Theranostics       Date:  2021-05-03       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.